Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fraser, R.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Drug use in gestational diabetes

Robert Fraser

Section of Reproductive and Developmental Medicine, University of Sheffield, Jessop Wing, Sheffield S10 2SF, UK, g.m.burkinshaw{at}sheffield.ac.uk

There has been a traditional reluctance to recommend oral antidiabetic drugs for the management of hyperglycaemia in gestational diabetes mellitus. Recent publications suggest that both sulphonylureas and metformin may have a contribution to therapy in this condition and in particular the Metformin in Gestational Diabetes (MiG) trial provides good quality evidence that this drug might be particularly suitable when obesity is a factor in gestational diabetes. This article gives an overview of the rationale for use of oral antidiabetic agents in the treatment of gestational diabetes. Br J Diabetes Vasc Dis 2009;9:33—35

Key Words: gestational diabetes • insulin therapy • oral antidiabetic drugs • metformin • glibenclamide • glyburide

The British Journal of Diabetes & Vascular Disease, Vol. 9, No. 1, 33-35 (2009)
DOI: 10.1177/1474651408101374
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
T. A Mahmood
Obesity: a reproductive hurdle
The British Journal of Diabetes & Vascular Disease, January 1, 2009; 9(1): 3 - 4.
[PDF]